Patterns of concurrent chemotherapy selection in US patients undergoing trimodality therapy for muscle-invasive bladder cancer

被引：0
|
作者：
Callihan, Eryn [1 ]
Kuna, Elizabeth Molina [2 ]
Robin, Tyler P. [3 ]
Eule, Corbin J. [4 ]
Kim, Simon P. [5 ]
Flaig, Thomas W. [1 ]
机构：
[1] Univ Colorado, Canc Ctr, Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Populat Hlth Shared Resource, Canc Ctr, Aurora, CO USA
[3] Univ Colorado Anschutz Med Campus, Aurora, CO USA
[4] Univ Colorado, Div Med Oncol, Canc Ctr, Aurora, CO USA
[5] Univ Colorado Denver, Dept Urol Oncol, Denver, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-566-148; 261-566-148-11342; 261-566-3248-2667; 283-183-138-226-11080; 6; 5; 3; 2; 176; 300; 62; 3590;
D O I：
10.1200/JCO.2024.42.4_suppl.554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：554 / 554
页数：1
相关论文
共 50 条
  • [21] Chemotherapy for Muscle-Invasive Bladder Cancer
    Patrizia Trenta
    Fabio Calabrò
    Linda Cerbone
    Cora N. Sternberg
    Current Treatment Options in Oncology, 2016, 17
  • [22] Current state of the art: Bladder-preserving trimodality therapy for muscle-invasive bladder cancer
    Efstathiou, Jason A.
    CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [23] Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Konieczkowski, David J.
    Efstathiou, Jason A.
    Mouw, Kent W.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (03) : 567 - 584
  • [24] Chemotherapy for Muscle-Invasive Bladder Cancer
    Trenta, Patrizia
    Calabro, Fabio
    Cerbone, Linda
    Sternberg, Cora N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (01) : 1 - 14
  • [25] Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional Experience
    Polineni, Praneet
    Ashack, Laura
    Kalapurakal, John
    Morgans, Alicia
    VanderWeele, David
    Kundu, Shilajit
    Hussain, Maha
    Meeks, Joshua
    Sachdev, Sean
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (05)
  • [26] Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer
    Bachir, Bassel G.
    Souhami, Luis
    Mansure, Jose Joao
    Cury, Fabio
    Vanhuyse, Marie
    Brimo, Fadi
    Aprikian, Armen G.
    Tanguay, Simon
    Sturgeon, Jeremy
    Kassouf, Wassim
    BLADDER CANCER, 2017, 3 (02) : 105 - 112
  • [27] Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
    Rose, Tracy L.
    Deal, Allison M.
    Ladoire, Sylvain
    Crehange, Gilles
    Galsky, Matthew D.
    Rosenberg, Jonathan E.
    Bellmunt, Joaquim
    Wimalasingham, Akhila
    Wong, Yu-Ning
    Harshman, Lauren C.
    Chowdhury, Simon
    Niegisch, Guenter
    Liontos, Michalis
    Yu, Evan Y.
    Pal, Sumanta K.
    Chen, Ronald C.
    Wang, Andrew Z.
    Nielsen, Matthew E.
    Smith, Angela B.
    Milowsky, Matthew, I
    BLADDER CANCER, 2016, 2 (04) : 405 - 413
  • [28] Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
    Elsayed, Dalia Hamouda
    Elfarargy, Ola M.
    Elderey, Mohamed Salah
    Mandour, Doaa
    Atef, Nora
    Hemeda, Rehab
    Kamel, Mostafa
    Azony, Ahmed
    Taha, Heba F.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (01): : 1 - 9
  • [29] Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: a decision analysis
    Lester-Coll, Nataniel H.
    Yu, James B.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2855 - S2857
  • [30] Mutational Landscape and Genetic Determinants of Response to Trimodality Therapy in Muscle-Invasive Bladder Cancer
    Miyamoto, D. T.
    Kamran, S. C.
    Mouw, K. W.
    Wu, C. L.
    Wu, S.
    Ukleja, J.
    Kusaka, E.
    Otani, K.
    Borger, D.
    Lennerz, J. K.
    Van Allen, E. M.
    Willers, H.
    Hong, T. S.
    Shipley, W. U.
    Efstathiou, J. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E861 - E861
12345